Lysodren Европска Унија - Исландски - EMA (European Medicines Agency)

lysodren

hra pharma rare diseases - mitotane - nýrnahettubólga - Æxlishemjandi lyf - einkenni meðferðar á háþróaðri (ómeðhöndluð, meinvörpum eða endurteknum) barkabólgu í nýrnahettum. Áhrif lysodren á virka ekki að mynda óeðlilega bylgja krabbamein er ekki stofnað.

Idotrim Filmuhúðuð tafla 160 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

idotrim filmuhúðuð tafla 160 mg

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 160 mg

Trimetoprim Meda Mixtúra, dreifa 10 mg/ml Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

trimetoprim meda mixtúra, dreifa 10 mg/ml

viatris aps - trimethoprimum inn - mixtúra, dreifa - 10 mg/ml

Zyvoxid Innrennslislyf, lausn 2 mg/ml Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

zyvoxid innrennslislyf, lausn 2 mg/ml

pfizer aps - linezolidum inn - innrennslislyf, lausn - 2 mg/ml

Idotrim Filmuhúðuð tafla 100 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

idotrim filmuhúðuð tafla 100 mg

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 100 mg

Isoptin retard Forðatafla 120 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

isoptin retard forðatafla 120 mg

viatris aps - verapamilum hýdróklóríð - forðatafla - 120 mg

Methylthioninium chloride Proveblue Европска Унија - Исландски - EMA (European Medicines Agency)

methylthioninium chloride proveblue

provepharm sas - metýlþíóníumklóríð - methemóglóbíndreyri - Öll önnur lækningavörur - bráð einkenni meðhöndlunar á methemóglóbíndreyri í lyfjum og efnaafurðum. methylthioninium i proveblue er ætlað í fullorðnir, börn og unglingar (aldrinum 0 til 17 ára).

Zydelig Европска Унија - Исландски - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Copiktra Европска Унија - Исландски - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Enalapril-Hydrochlorthiazid Krka Tafla 20 mg /12,5 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril-hydrochlorthiazid krka tafla 20 mg /12,5 mg

krka sverige ab - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg /12,5 mg